KRSNAA

Krsnaa Diagnostics vs Peers

₹530.00-3.30%close, 9 Oct 2026
Market cap
₹1,719 crore
P/E
22.5
P/B
2.85
ROE
14.5%
Dividend yield
1.20%
52-week range
₹381.60 – ₹715.50

Krsnaa Diagnostics ranks 1st by market capitalisation among 1 Diagnostics & Research companies tracked by ATS. Its largest peers are Krsnaa Diagnostics. Its P/E of 22.5 compares with a peer median of 22.5.

Krsnaa Diagnostics vs Diagnostics & Research peers

Sorted by market capitalisation.

Krsnaa Diagnostics and peers compared on size, valuation and returns
CompanyClose (₹)1DMarket cap (₹ cr)P/EP/BROE1Y return
Krsnaa Diagnostics530.00-3.30%1,71922.52.8514.5%+18.5%
Krsnaa Diagnostics530.00-3.30%1,71922.52.8514.5%+24.5%

Source: NSE end-of-day prices; ratios from company filings. Data as of 9 October 2026. How this data is compiled.

Krsnaa Diagnostics peer comparison — frequently asked questions

Who are Krsnaa Diagnostics' competitors?

Krsnaa Diagnostics' listed peers in Diagnostics & Research include Krsnaa Diagnostics, ranked here by market capitalisation.

How does Krsnaa Diagnostics' P/E compare with its peers?

Krsnaa Diagnostics trades at a P/E of 22.5, against a median of 22.5 across the 1 Diagnostics & Research peers shown.

Which is the largest company among Krsnaa Diagnostics' peers?

By market capitalisation, the largest company in the group is Krsnaa Diagnostics at ₹1,719 crore, against ₹1,719 crore for Krsnaa Diagnostics.

Same Data For Peers

Trade Krsnaa Diagnostics With ATS

Track KRSNAA live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.

Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.